LMIR5 extracellular domain activates myeloid cells through Toll-like receptor 4

Molecular Immunology

Volumn 62, Issue 1, 2014, Pages 169-177

  Phongsisay, Vongsavanh ^a   Iizasa, Ei'ichi ^b   Hara, Hiromitsu ^b   Yamasaki, Sho ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

CD300b; Inflammation; LMIR5; TLR4

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; LECTIN RECEPTOR; LMIR5 FC PROTEIN; LMIR5 PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYMYXIN B; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; LIGAND; LMIR5 PROTEIN, MOUSE; PROTEIN BINDING; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CARDIOTOXICITY; CELL ACTIVATION; CELL SURFACE; CYTOKINE PRODUCTION; DENDRITIC CELL; EPITHELIUM CELL; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; MACROPHAGE; MAST CELL; MICROGLIA; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; EXTRACELLULAR SPACE; HEK293 CELLS; HUMANS; INFLAMMATION; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84903832811     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.06.012     Document Type: Article

References (29)

1. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
2. Arribillaga L., Durantez M., Lozano T., Rudilla F., Rehberger F., Casares N., Villanueva L., Martinez M., Gorraiz M., Borras-Cuesta F., Sarobe P., Prieto J., Lasarte J.J. A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo. BioMed Res. Int. 2013, 2013:864720.
3. Brigotti M., Carnicelli D., Arfilli V., Tamassia N., Borsetti F., Fabbri E., Tazzari P.L., Ricci F., Pagliaro P., Spisni E., Cassatella M.A. Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils. J. Immunol. 2013, 191:4748-4758.
4. Ding Q., Yeung M., Camirand G., Zeng Q., Akiba H., Yagita H., Chalasani G., Sayegh M.H., Najafian N., Rothstein D.M. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J. Clin. Invest. 2011, 121:3645-3656.
5. Gasiorowski R.E., Ju X., Hart D.N., Clark G.J. CD300 molecule regulation of human dendritic cell functions. Immunol. Lett. 2013, 149:93-100.
6. Hara H., Ishihara C., Takeuchi A., Imanishi T., Xue L., Morris S.W., Inui M., Takai T., Shibuya A., Saijo S., Iwakura Y., Ohno N., Koseki H., Yoshida H., Penninger J.M., Saito T. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 2007, 8:619-629.
7. Higgins S.C., Jarnicki A.G., Lavelle E.C., Mills K.H. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 2006, 177:7980-7989.
8. Hutchens M.A., Luker K.E., Sonstein J., Nunez G., Curtis J.L., Luker G.D. Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection. PLoS Pathog. 2008, 4:e1000153.
9. Hwang I.Y., Park C., Harrison K., Kehrl J.H. TLR4 signaling augments B lymphocyte migration and overcomes the restriction that limits access to germinal center dark zones. J. Exp. Med. 2009, 206:2641-2657.
10. Kandadi M.R., Frankel A.E., Ren J. Toll-like receptor 4 knockout protects against anthrax lethal toxin-induced cardiac contractile dysfunction: role of autophagy. Br. J. Pharmacol. 2012, 167:612-626.
11. Kerfoot S.M., Long E.M., Hickey M.J., Andonegui G., Lapointe B.M., Zanardo R.C., Bonder C., James W.G., Robbins S.M., Kubes P. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol. 2004, 173:7070-7077.
12. Lartigue A., Colliou N., Calbo S., Francois A., Jacquot S., Arnoult C., Tron F., Gilbert D., Musette P. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J. Immunol. 2009, 183:6207-6216.
13. + T cells. Nat. Med. 2010, 16:713-717.
14. Martinez-Barriocanal A., Comas-Casellas E., Schwartz S., Martin M., Sayos J. CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. J. Biol. Chem. 2010, 285:41781-41794.
15. Martinez-Barriocanal A., Sayos J. Molecular and functional characterization of CD300b, a new activating immunoglobulin receptor able to transduce signals through two different pathways. J. Immunol. 2006, 177:2819-2830.
16. Park S.Y., Ueda S., Ohno H., Hamano Y., Tanaka M., Shiratori T., Yamazaki T., Arase H., Arase N., Karasawa A., Sato S., Ledermann B., Kondo Y., Okumura K., Ra C., Saito T. Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J. Clin. Invest. 1998, 102:1229-1238.
17. Qiang X., Yang W.L., Wu R., Zhou M., Jacob A., Dong W., Kuncewitch M., Ji Y., Yang H., Wang H., Fujita J., Nicastro J., Coppa G.F., Tracey K.J., Wang P. Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsis. Nat. Med. 2013, 19:1489-1495.
18. Quintana F.J., Cohen I.R. Heat shock proteins as endogenous adjuvants in sterile and septic inflammation. J. Immunol. 2005, 175:2777-2782.
19. Roger T., Froidevaux C., Le Roy D., Reymond M.K., Chanson A.L., Mauri D., Burns K., Riederer B.M., Akira S., Calandra T. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc. Nat. Acad. Sci. U.S.A. 2009, 106:2348-2352.
20. Turnbull I.R., Colonna M. Activating and inhibitory functions of DAP12. Nat. Rev. Immunol. 2007, 7:155-161.
21. van Sorge N.M., Bleumink N.M., van Vliet S.J., Saeland E., van der Pol W.L., van Kooyk Y., van Putten J.P. N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL. Cell. Microbiol. 2009, 11:1768-1781.
22. Vogl T., Tenbrock K., Ludwig S., Leukert N., Ehrhardt C., van Zoelen M.A., Nacken W., Foell D., van der Poll T., Sorg C., Roth J. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 2007, 13:1042-1049.
23. Xu J., Zhang X., Monestier M., Esmon N.L., Esmon C.T. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J. Immunol. 2011, 187:2626-2631.
24. Xu J., Zhang X., Pelayo R., Monestier M., Ammollo C.T., Semeraro F., Taylor F.B., Esmon N.L., Lupu F., Esmon C.T. Extracellular histones are major mediators of death in sepsis. Nat. Med. 2009, 15:1318-1321.
25. Yamanishi Y., Kitaura J., Izawa K., Kaitani A., Komeno Y., Nakamura M., Yamazaki S., Enomoto Y., Oki T., Akiba H., Abe T., Komori T., Morikawa Y., Kiyonari H., Takai T., Okumura K., Kitamura T. TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J. Exp. Med. 2010, 207:1501-1511.
26. Yamanishi Y., Kitaura J., Izawa K., Matsuoka T., Oki T., Lu Y., Shibata F., Yamazaki S., Kumagai H., Nakajima H., Maeda-Yamamoto M., Tybulewicz V.L., Takai T., Kitamura T. Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells. Blood 2008, 111:688-698.
27. Yamanishi Y., Takahashi M., Izawa K., Isobe M., Ito S., Tsuchiya A., Maehara A., Kaitani A., Uchida T., Togami K., Enomoto Y., Nakahara F., Oki T., Kajikawa M., Kurihara H., Kitamura T., Kitaura J. A soluble form of LMIR5/CD300b amplifies lipopolysaccharide-induced lethal inflammation in sepsis. J. Immunol. 2012, 189:1773-1779.
28. Yamasaki S., Ishikawa E., Sakuma M., Hara H., Ogata K., Saito T. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol. 2008, 9:1179-1188.
29. Yang H., Hreggvidsdottir H.S., Palmblad K., Wang H., Ochani M., Li J., Lu B., Chavan S., Rosas-Ballina M., Al-Abed Y., Akira S., Bierhaus A., Erlandsson-Harris H., Andersson U., Tracey K.J. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Nat. Acad. Sci. U.S.A. 2010, 107:11942-11947.